
This website uses cookies to ensure you get the best experience on our website. By using our site, you are agreeing to our use of cookies.
More info



Korab Zuka leads global efforts at Novartis to embed social impact and sustainability into the core of the business. His work centres on maximising the impact of our medicines through innovation in access models and partnerships that extend reach to underserved communities. With a proven track record in building impactful partnerships and driving health equity, sustainability, and social impact initiatives, Korab has contributed significantly to both private and public healthcare organisations. He has held senior leadership roles at Bristol Myers Squibb and Gilead Sciences, where he developed programmes that delivered measurable impact across global health and environmental priorities. Korab’s approach is rooted in the belief that meaningful progress in health can only be achieved through collaboration. He champions cross-sector partnerships that strengthen the broader ecosystem and drive long-term, inclusive outcomes. |

This website uses cookies to ensure you get the best experience on our website. By using our site, you are agreeing to our use of cookies.